Safe Medicine Act

Hozzl · 2022-02-09T01:42:21Z

Explore the details of House Bill 5927 Safe Medicine Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/9/2022, 1:42 AM

Congressional Summary of HR 5927

Safe Medicine Act

This bill authorizes the Food and Drug Administration to temporarily ban the sale of a drug if (1) the drug (or an active ingredient of the drug) is manufactured in a country that, because of systemic problems of supervision, may be producing contaminated drugs; and (2) the drug's labeling does not have certain warnings about potential contamination.

The bill also requires the Department of Health and Human Services to report to Congress on vulnerabilities in the U.S. medicine supply chain, including vulnerabilities related to reliance on production from other countries.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5927

Bill HR 5927 is currently in the status of Bill Introduced since February 18, 2020. Bill HR 5927 was introduced during Congress 116 and was introduced to the House on February 18, 2020. Bill HR 5927's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 18, 2020

Bipartisan Support of Bill HR 5927

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5927

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Asia

- China

- Congressional oversight

- Drug safety, medical device, and laboratory regulation

- Government studies and investigations

- Health care costs and insurance

- Health information and medical records

- Health technology, devices, supplies

- Manufacturing

- Prescription drugs

- Public contracts and procurement

- Trade restrictions

Alternate Title(s) of Bill HR 5927

Safe Medicine Act

To direct the Secretary of Health and Human Services to study American dependence on unsafe Chinese pharmaceuticals and to empower the Food and Drug Administration to mandate drug recalls in the case of critical contamination.

Safe Medicine Act